NEW DELHI, India — Indian scientists have developed a new experimental cancer drug designed to activate mainly inside tumour cells while remaining relatively inactive in healthy tissue, offering a potential targeted approach to cancer treatment. The drug, named RK-251, was developed through collaborative research involving the Institute of Advanced Study in Science and Technology and the Indian Institute of Technology-Guwahati.